Portal de Periódicos da CAPES

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection

2021; Elsevier BV; Volume: 2; Issue: 3 Linguagem: Inglês

10.1016/j.medj.2021.02.001

2666-6359

Natalia Sherina, Antonio Piralla, Likun Du, Hui Wan, Makiko Kumagai‐Braesch, Juni Andréll, Sten Braesch‐Andersen, Irene Cassaniti, Elena Percivalle, Antonella Sarasini, Federica Bergami, Raffaella Di Martino, Marta Colaneri, Marco Vecchia, Margherita Sambo, Valentina Zuccaro, Raffaele Bruno, Michele Sachs, Tiberio Oggionni, Federica Meloni, Hassan Abolhassani, Federico Bertoglio, Maren Schubert, Miranda Byrne‐Steele, Jian Han, Michael Hust, Yintong Xue, Lennart Hammarström, Fausto Baldanti, Harold Marcotte, Qiang Pan‐Hammarström,

Long-Term Effects of COVID-19

Monitoring the adaptive immune responses during the natural course of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection provides useful information for the development of vaccination strategies against this virus and its emerging variants. We thus profiled the serum anti-SARS-CoV-2 antibody (Ab) levels and specific memory B and T cell responses in convalescent coronavirus disease 2019 (COVID-19) patients.